Country: Ástralía
Tungumál: enska
Heimild: APVMA (Australian Pesticides and Veterinary Medicines Authority)
MELOXICAM
CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED
ORAL GRANULES, PELLETS
MELOXICAM UNGROUPED Active 330.0 mg/Sa
100sachets; 20 sachets
VM - Veterinary Medicine
MUSCULOSKELETAL SYSTEM
Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [MUSCULOSKELETAL CONDITIONS]
Registered
2023-07-01
Product Name: APVMA Approval No: Inflacam Granules for Horses 87755/119164 Label Name: Inflacam Granules for Horses Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: Each sachet contains 330 mg MELOXICAM Claims: Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in horses. Net Contents: 20 sachets 100 sachets Directions for Use: Restraints: DO NOT USE in horses that may be used for human consumption. Contraindications: Contraindicated for use in pregnant or lactating mares as no data has been established. Contraindicated for use in horses less than 6 weeks of age. Contraindicated for use in animals suffering from gastrointestinal disorders, such as irritation, haemorrhage and gastric ulceration. Contraindicated for use in animals suffering from impaired hepatic, cardiac or renal function and haemorrhagic disorders or where there is evidence of individual hypersensitivity to the active substance. Contraindicated for concurrent administration with glucocorticoids or other NSAIDs, or with anti-coagulant agents. Precautions: Avoid introduction of contamination during use. Avoid use in dehydrated, hypovolaemic or hypotensive animals, as there is a potential risk of increased renal toxicity. If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought. RLP APPROVED Side Effects: Reversible side effects consistent with the use of non-steroidal anti-inflammatory drugs (NSAIDs) may be observed, e.g. slight urticaria and diarrhoea. In very rare cases loss of appetite, lethargy, abdominal pain and colitis may occur. In very rare cases anaphylactoid reactions which may be serious (including fatal) may occur and should be treated symptomatically. If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought. Overdose: In the case of overdosing a symptomatic treatment should be initiated. Dosage and Administration: For Lestu allt skjalið